THINK Surgical Receives FDA 510(k) Clearance for TMINI Miniature Robotic System (TMINI 1.1)

FREMONT, Calif., July 23, 2024 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System (TMINI 1.1) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). 

The TMINI 1.1 system software provides substantial new capabilities empowering surgeon choice throughout total knee arthroplasty procedures.  The new TMINI PRO workflow, enables Positional Refinement and Optimization of the implant tailored to the patient’s needs. The workflow’s dynamic data capture and real-time feedback allows surgeons to make positional adjustments to help fine-tune implant positioning and stability. The TMINI PRO workflow is intuitive and customizable around surgeon preferences and implant philosophy choices. Surgical plan adjustments are wirelessly transmitted to the TMINI Robot for a seamless surgical experience. 

“The new TMINI PRO workflow enabled by the updated TMINI 1.1 software provides me with everything I need from robotics for my total knee replacements,” said Dr. Alexander Sah, Co-Director of the Institute of Joint Restoration. “The added ability to assess real-time soft tissue balance intraoperatively and to adjust my plan according to my preferences in the OR helps me deliver the best possible outcomes for my patients.” 

Sign up for Blog Updates